Lululemon released fiscal third-quarter financial results after markets closed Wednesday. The company said that it had $0.96 in earnings per share (EPS) and $916 million in revenue, compared with consensus estimates that called for…
Correvio Pharma shares were crushed after the firm announced the FDA Cardiovascular and Renal Drugs Advisory Committee decision for its New Drug Application seeking approval for Brinavess. This could result in a sale of…
Lululemon is scheduled to release its fiscal third-quarter financial results after the markets close on Wednesday.
Proteostasis shares jumped on Wednesday after the firm announced positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance regulator modulators, PTI-801, PTI-808 and PTI-428.
Nike has been an outstanding Dow component so far in 2019, despite its exposure to China. Even though trade talks are ongoing and nothing has been fully resolved yet, one analyst sees Nike’s outperformance…
The November 29 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 29 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
GameStop released fiscal third-quarter financial results after markets closed Tuesday. The video game retailer said that it had a net loss of $0.49 per share and $1.44 billion in revenue, compared with consensus estimates…
Wedbush has a cautious view of many homebuilders for 2020 after noting that there will be tougher comps in the second half of the year while it actually sees the near-term setup as enticing.
Needham on Tuesday downgraded Netflix and said it anticipated millions of subscriber losses in 2020 amid increasing competition in the streaming market.
RBC Capital Markets has taken a renewed look at the restaurant industry, and the firm sees some serious upside for some major names within the industry.
Dermira shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track designation for lebrikizumab, its treatment moderate-to-severe atopic dermatitis.
Conn’s is yet another firm getting shipped off to the island of misfit retailers after posting its most recent financial results before the opening bell on Tuesday.
Texas-based furniture and appliances retailer Conn’s is scheduled to release its fiscal third-quarter before the opening bell on Tuesday.
Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal master engineered induced pluripotent stem cell line.
Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a few of these standouts…
The third-quarter earnings reporting season has wound down, but a few more major companies still will be sharing their results in this week.
Sage Therapeutics shareholders took a bath on Thursday after results from its late-stage major depressive disorder trial came public.
